{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:13Z","timestamp":1791223513850,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.vaccine.2007.12.040","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T12:30:53Z","timestamp":1200832253000},"page":"1353-1364","source":"Crossref","is-referenced-by-count":44,"title":["Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a"],"prefix":"10.1016","volume":"26","author":[{"given":"K. Ross","family":"Turbyfill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin V.","family":"Oaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.12.040_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/00365549309008545","article-title":"Serum antibody responses against Shigella lipopolysaccharides and invasion plasmid-coded antigens in Shigella infected Swedish patients","volume":"25","author":"Li","year":"1993","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.040_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/IAI.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in Rhesus monkeys and humans infected with Shigella spp.","volume":"53","author":"Oaks","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2958.1996.tb02656.x","article-title":"Effect of O side-chain length and composition on the virulence of Shigella flexneri 2a","volume":"22","author":"Sandlin","year":"1996","journal-title":"Mol Microbiol"},{"issue":"5713","key":"10.1016\/j.vaccine.2007.12.040_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1108472","article-title":"Optimization of virulence functions through glucosylation of Shigella LPS","volume":"307","author":"West","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.12.040_bib5","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1128\/IAI.68.12.6624-6632.2000","article-title":"Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine","volume":"68","author":"Turbyfill","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib6","series-title":"Immunological and functional characterization of a novel mucosal adjuvant isolated from Shigella spp. [Doctoral]","author":"Kaminski","year":"2004"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.040_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/IAI.18.1.94-98.1977","article-title":"Detection and differentiation of iron\u2013responsive avirulent mutants on Congo red agar","volume":"18","author":"Payne","year":"1977","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.12.040_bib8","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/IAI.56.11.2933-2941.1988","article-title":"Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies","volume":"56","author":"Mills","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-4838(98)00213-1","article-title":"Protein\u2013protein interactions in the assembly of Shigella flexneri invasion plasmid antigens IpaB and IpaC into protein complexes","volume":"1429","author":"Davis","year":"1998","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.vaccine.2007.12.040_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/prep.1996.0117","article-title":"expression, and affinity purification of recombinant Shigella flexneri invasion plasmid antigens IpaB and IpaC","volume":"8","author":"Picking","year":"1996","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2007.12.040_bib11","first-page":"83","article-title":"Bacterial Lipopolysaccharides. Extraction with phenol water and further applications of the procedure","volume":"5","author":"Westphal","year":"1965","journal-title":"Methods Carbohydr Chem"},{"key":"10.1016\/j.vaccine.2007.12.040_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0264-410X(93)90016-Q","article-title":"Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model","volume":"11","author":"Mallett","year":"1993","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2007.12.040_bib13","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/IAI.59.11.4075-4083.1991","article-title":"Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains","volume":"59","author":"Hartman","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/CDLI.3.5.584-589.1996","article-title":"Specificity of monoclonal antibodies elicited by mucosal infection of BALB\/c mice with virulent Shigella flexneri 2a","volume":"3","author":"Hartman","year":"1996","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.12.040_bib15","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1128\/IAI.66.5.1999-2006.1998","article-title":"Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD)","volume":"66","author":"Turbyfill","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib16","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.vaccine.2005.11.040","article-title":"Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine","volume":"24","author":"Oaks","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.040_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1083\/jcb.147.3.683","article-title":"The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host\u2013membranes","volume":"147","author":"Blocker","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2007.12.040_bib18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1073\/pnas.93.3.1254","article-title":"The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells","volume":"93","author":"Menard","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.12.040_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1462-5822.1999.00019.x","article-title":"The secreted IpaB and IpaC invasins and their cytoplasmic chaperone IpgC are required for intercellular dissemination of Shigella flexneri","volume":"1","author":"Page","year":"1999","journal-title":"Cell Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.12.040_bib20","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1128\/IAI.00440-06","article-title":"IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri","volume":"74","author":"Espina","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib21","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.63.6.2382-2386.1995","article-title":"Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection","volume":"63","author":"Mallett","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib22","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/IAI.69.7.4545-4553.2001","article-title":"Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults","volume":"69","author":"Fries","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.12.040_bib23","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/IAI.61.6.2390-2395.1993","article-title":"Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome\u2013lipopolysaccharide vaccines in animal models","volume":"61","author":"Orr","year":"1993","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.12.040_bib24","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1128\/IAI.68.6.3710-3715.2000","article-title":"Interaction of Shigella flexneri IpaC with model membranes correlates with effects on cultured cells","volume":"68","author":"Tran","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.12.040_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2958.2000.02027.x","article-title":"Membrane fusion activity of purified SipB, a Salmonella surface protein essential for mammalian cell invasion","volume":"37","author":"Hayward","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.040_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2958.2003.03559.x","article-title":"The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology","volume":"49","author":"Hume","year":"2003","journal-title":"Mol Microbiol"},{"issue":"22","key":"10.1016\/j.vaccine.2007.12.040_bib27","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/j.1460-2075.1994.tb06863.x","article-title":"The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD","volume":"13","author":"Menard","year":"1994","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.040_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","article-title":"Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice","volume":"67","author":"Saunders","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.12.040_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/IAI.6.5.835-851.1972","article-title":"Isolation and characterization of a native cell wall complex from Neisseria meningitidis","volume":"6","author":"Zollinger","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.040_bib30","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.42.6.1476","article-title":"Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles","volume":"42","author":"Kadurugamuwa","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2007.12.040_bib31","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1099\/13500872-145-8-2051","article-title":"Membrane vesicles derived from Pseudomonas aeruginosa and Shigella flexneri can be integrated into the surfaces of other Gram-negative bacteria","volume":"145","author":"Kadurugamuwa","year":"1999","journal-title":"Microbiology"},{"issue":"7","key":"10.1016\/j.vaccine.2007.12.040_bib32","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.4049\/jimmunol.177.7.4709","article-title":"High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin","volume":"177","author":"Suzuki","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07015137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07015137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T23:32:36Z","timestamp":1588289556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07015137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0264410X07015137"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}